• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Med Virol A Newly Developed Real-Time PCR Assay for Discriminating Influenza B Virus Yamagata and Victoria Lineages

tetano

Editor, Senior Moderator
J Med Virol


. 2020 Jun 4.
doi: 10.1002/jmv.26133. Online ahead of print.
A Newly Developed Real-Time PCR Assay for Discriminating Influenza B Virus Yamagata and Victoria Lineages


Jinli Wei[SUP] 1 [/SUP], Huaxin Huang[SUP] 1 [/SUP], Hucheng Qin[SUP] 1 [/SUP], Shanqin Li[SUP] 2 [/SUP], Li Xing[SUP] 1 [/SUP], Yanjie Li[SUP] 1 [/SUP], Mengli Cao[SUP] 1 [/SUP], Yanrong Wang[SUP] 1 [/SUP], Yuhai Bi[SUP] 1 2 [/SUP], Yingxia Liu[SUP] 1 3 [/SUP], Yang Yang[SUP] 1 [/SUP]



Affiliations

Abstract

Background: Currently, two distinct lineages of influenza B virus (IBV), B/Victoria and B/Yamagata lineage, have been co-circulating in human beings. Assessment of the prevalent lineage is key for the recommendation of the seasonal influenza vaccine composition and the evaluation of its efficacy.
Materials and methods: A multiplex qRT-PCR assay for the discrimination of the IBV lineages was designed based on the genetic differences of the HA genes between B/Yamagata and B/Victoria lineages. This assay was further tested for specificity and sensitivity, and validated using clinical samples and virus isolates.
Results: The assay was highly specific and able to discriminate the lineages of IBV without any non-specific reaction against other influenza A viruses. The detection limit of the assay was determined to be 10 genome-equivalent copies and 2.8 ? 10[SUP]-2[/SUP] 50% tissue culture infectious doses (TCID[SUB]50[/SUB] ) of live IBV per reaction. Moreover, our assay was able to discriminate the lineages of IBVs in clinical samples with 100% accuracy, when compared with pyrosequencing.
Conclusions: Our results indicate that this assay may represent an update of the existing qRT-PCR assays and will be of great use for the rapid and accurate diagnosis and surveillance of the circulating IBVs. This article is protected by copyright. All rights reserved.

Keywords: B/Victoria and B/Yamagata, lineages; discrimination; influenza B virus; real-time PCR.



This article is protected by copyright. All rights reserved.
 
Back
Top Bottom